A Phase II Randomised Controlled Trial of Adjuvant Tumour-Infiltrating Lymphocytes for Pretreatment Epstein-Barr Virus DNA-selected High-Risk Nasopharyngeal Carcinoma Patients.
EUROPEAN JOURNAL OF CANCER（2023）
关键词
Adoptive immunotherapy,Tumour-infiltrating lymphocytes,Epstein-Barr Virus DNA,High-risk,Nasopharyngeal carcinoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要